StockData
DexCom Inc logo

DexCom Inc

DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3033% below fair value
$79.32−0.87 (-1.08%)

Close on Nov 20, 2026Market cap $29.58BP/E 31.2Yield –

DexCom Annual Net Active Customer Additions by Year

Annual Net Active Customer Additions — High Bound (M)

DexCom Annual Net Active Customer Additions: 0.70M in FY2025, up 16.7% from a year earlier.

Latest, FY2025
0.70
Period ended Dec 31, 2025
Change on a year earlier
+16.7%
0.60 in FY2024
History
2 years
Since FY2024
Sources
2
Documents cited below

Where the FY2025 figure comes from

“We added approximately 600,000 - 700,000 net customers, excluding Stelo customers, to our worldwide customer base in 2025.”

Source: 10-K (FY2025, filed 2026-02-12) ↗

Upper bound of reported annual net customer additions (excluding Stelo): 500,000–600,000 in FY2024 and 600,000–700,000 in FY2025.

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAnnual Net Active Customer Additions — High Bound (M)Year on yearSource
FY2025Dec 31, 20250.70+16.7%10-K (FY2025, filed 2026-02-12) ↗
FY2024Dec 31, 20240.60–10-K (FY2024, filed 2025-02-18) ↗

Cite this data

StockData. (2026). DexCom Annual Net Active Customer Additions (M), annual FY2024–FY2025 [Data set]. Compiled from DexCom SEC filings and investor materials. https://stockdatahq.com/stocks/dxcm/kpis/cust-net-add-high

See every metric in the DexCom KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?